Chigasaki, Japan

Tomoyuki Ishikura

USPTO Granted Patents = 31 

Average Co-Inventor Count = 5.5

ph-index = 7

Forward Citations = 228(Granted Patents)


Location History:

  • Kanagawa, JP (1984 - 1985)
  • Chigasaki, JP (1982 - 1991)

Company Filing History:


Years Active: 1982-1991

Loading Chart...
31 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Tomoyuki Ishikura and His Contributions to Antibiotics

Introduction: Tomoyuki Ishikura, a distinguished inventor based in Chigasaki, Japan, has made significant strides in the field of pharmaceuticals with a prolific portfolio of 31 patents to his name. His innovations primarily focus on the development of antibiotic compounds, specifically in the carbapenem series, which are vital in combating bacterial infections and improving health outcomes.

Latest Patents: Among his latest patents, Ishikura has developed 6-(disubstituted amino)carbapenem compounds. These compounds are characterized by a specific formula where R1 represents a lower alkyl group or a lower haloalkyl group, while R2 can be a range of organic groups, including lower alkyl and aralkyl groups. The utility of these compounds lies in their potential as precursors for synthesizing a range of effective 6-(disubstituted amino)carbapenem-series antibiotics. Furthermore, his work on optically active azetidinones signifies his commitment to refining antibiotic efficacy, showcasing his deep understanding of medicinal chemistry.

Career Highlights: Ishikura has held key positions at leading companies such as Sanraku-Ocean Co., Ltd. and Sanraku Incorporated, where he has collaborated on groundbreaking research and development projects. His contributions have not only advanced the field of antibiotic development but have also established him as a valuable asset in pharmaceutical innovation.

Collaborations: Throughout his career, Tomoyuki Ishikura has worked alongside notable colleagues, including Yasuo Fukagawa and Takeo Yoshioka. These collaborations have fostered a rich environment for innovation, allowing for the exchange of ideas and expertise that have propelled their joint research initiatives forward.

Conclusion: Tomoyuki Ishikura's impressive array of patents and his unwavering dedication to improving antibiotic solutions highlight his status as a pivotal figure in pharmaceutical innovation. His latest developments promise to enhance the treatment landscape for bacterial infections, ensuring he remains at the forefront of medical advancements. As the global demand for effective antibiotics continues to rise, Ishikura's innovations will undoubtedly play a crucial role in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…